Sino Biopharmaceutical
Bookmark
ShareCopied to clipboardSino Biopharmaceutical is a company. It is a public company in Wan Chai, China. It was founded in 2000 and its current CEO is Eric S. Y. Tse. It is part of the Health Care sector, specifically in the Biotechnology industry.
Key facts
- city: Wan Chai
- country: China
- employees: 24,437 people
- revenues: 3.8B $
- company type: public
- sector: Health Care
- industry: Biotechnology
- foundation year: 2000
- CEO: Eric S. Y. Tse
- ESG score: Try Pro to see estimate
See more facts
Extract data
Download datasets about Sino Biopharmaceutical:
Dataset of stocks from Sino Biopharmaceutical:
Sino Biopharmaceutical is one of the companies in China, companies in Biotechnology, companies in Health Care, companies in Wan Chai and 3,456,808 companies in our database.
Talking Points
- 中国生物制药有限公司
- Sino Biopharmaceutical Limited and its subsidiaries are the leading innovative research and R&D-driven pharmaceutical group in China, with a business scope that...
- Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company's products include oncology medicines comprising Qingkeshu tablets, Anxian capsules, Yinishu tablets, Genike capsules, Anyue capsules, and Leweixin injections; cardio-cerebral vascular medicines, including Kaina and Anrixin tablets; hepatitis medicines, such as Tianqingganmei injections and Tianqingganping enteric capsules; orthopedic medicines consisting of Gaisanchun capsules, Yigu injections, and Taiyan tablets; respiratory system medicines; parenteral nutritious medicines comprising Xinhaineng and Fenghaina injections; and other medicines, including Tuotuo tablets, Debaian cataplasms, and Qingliming injections. It also offers Aprepitant capsules, Lenvatinib Mesilate capsules, Vortioxetine Hydrobromide tablets, Edaravone injection, Amlodipine Besylate and Atorvastatin Calcium tablets, Sofosbuvir tablets, Sitagliptin Phosphate tablets, Colistimethate Sodium for injection, and Tofacitinib Citrate tablets. In addition, the company holds properties; retails and distributes pharmaceutical products; offers optometry for optical glasses and sells ophthalmic products; operates hospitals; provides medical management and health information consultancy, as well as bio-tech transfer and consultation services; manufactures and sells health food; and offers orthopedic outpatient and surgical procedures. Further, it manufactures, sells, and distributes health food; develops medical and health technology; trades in optical glasses; and researches, develops, and sells medical devices and active pharmaceutical ingredients. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.